$0.001 0.0 0.0%
Last Trade - 15/01/21
| Market Cap | £10.5k |
| Enterprise Value | £65.6k |
| Revenue | £n/a |
| Position in Universe | th / 6554 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015E | 2016E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.037 | 0.18 | 0.17 | 0.000 | 0.000 | 0.000 | -100.0% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Verde Science, Inc. is a pharmaceutical research and development company. The Company is engaged in medical science consulting business. The Company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. The Company is focused on developing medicinal formulations from cannabinoids and tetrahydrocannabinol (THC) compounds for the treatment of various issues, such as migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues. The Company is focused on launching its THC Pharmaceutical Development Program by executing a research program, which involves developing formulations preparing protocols for clinical trials.
| Last Annual | December 31st, 2014 |
| Last Interim | September 30th, 2015 |
| Incorporated | January 31, 2007 |
| Public Since | January 31, 2007 |
| No. of Shareholders: | n/a |
| No. of Employees: | 1 |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 23,867,679 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 8275 S Eastern Ave Ste 200, LAS VEGAS, 89123-2545, United States |
| Web | http://verdescienceinc.com/ |
| Phone | +1 702 5952247 |
| Contact | () |
| Auditors | M&K CPAS PLLC |
As of 15/01/21, shares in Verde Science Inc are trading at $0.001, giving the company a market capitalisation of £10.5k. This share price information is delayed by 15 minutes.
Shares in Verde Science Inc are currently trading at $0.001 and the price has moved by -40% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Verde Science Inc price has moved by -47.23% over the past year.
There are no analysts currently covering Verde Science Inc.
Verde Science Inc is scheduled to issue upcoming financial results on the following dates:
Verde Science Inc does not currently pay a dividend.
Verde Science Inc does not currently pay a dividend.
Verde Science Inc does not currently pay a dividend.
To buy shares in Verde Science Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Verde Science Inc are currently trading at $0.001, giving the company a market capitalisation of £10.5k.
Here are the trading details for Verde Science Inc:
We were not able to load our ranking data for Verde Science Inc
We were not able to load any forecast data for Verde Science Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Verde Science Inc. Over the past six months, the relative strength of its shares against the market has been 25.1%. At the current price of $0.001, shares in Verde Science Inc are trading at -57.33% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Verde Science Inc.
Verde Science Inc's management team is headed by:
Here are the top five shareholders of Verde Science Inc based on the size of their shareholding:
